The True Cost of Outsourcing Medical Sales in 2026

A VP of Sales called me in February wanting to "outsource his pharma sales." He'd already had a demo from Amplity and was comparing proposals. He wanted a second opinion.

Twenty minutes in, I realized he didn't actually want to outsource. He had two vacant territories and a board meeting in six weeks. "Outsourcing" was just the word he'd latched onto because someone had pitched it to him. What he wanted was coverage, fast, without committing to two more W2 headcount before he had revenue data.

That's a different problem. And Amplity's proposal — which included a twelve-month minimum and a setup fee north of $30K — was the wrong answer to it.

"Outsourcing medical sales" gets used like it means one decision. It doesn't. You are usually choosing between three very different operating models with different cost, risk, and management requirements. If you skip that distinction, proposal comparisons become mostly noise.

Disclaimer: all pricing, timing, and performance figures in this article are directional estimates based on limited samples and should not be treated as guarantees.

Model One: W2 Employees

Not outsourcing. I include it because every cost analysis that leaves it out is trying to make the alternatives look cheaper than they are.

A rep at $80K base costs you $100K-$108K loaded after benefits. Add recruiting — $18K-$35K per hire if you're using an agency, less if you're pulling internally but not zero. First-year total for one rep in a mid-tier specialty: call it $118K-$143K, assuming they're productive by month five. That last part is optimistic in pharma and device.

The W2 model isn't bad. It's just slow and front-loaded. You're paying full cost before you have proof the territory is worth it.

Model Two: Traditional CSOs

Amplity, IQVIA, Syneos. Large infrastructure, genuine deployment capability, and pricing that is almost never published upfront.

Setup fees run $15K-$40K. Monthly per-rep fees in the programs I've had visibility into are $12K-$18K, sometimes with revenue-based components stacked on top. Those numbers are from about eight CSO comparisons I've been involved in over the past two years — not a huge sample, and your program specifics will shift things. But it gives you a frame.

The part that actually matters: minimum contract terms. Almost always twelve months. Often eighteen to twenty-four. If you sign a twenty-four-month CSO agreement and the product struggles at month eight, you're paying for reps you don't need for another sixteen months. The CSO carries the deployment risk. You carry everything else.

There's also the shared-rep issue. In smaller programs, reps often cover multiple clients. That's not necessarily disclosed in the proposal. Your rep isn't thinking about your product all day — they're managing a book of accounts across different companies. Fine for some products. A real problem for anything that needs deep clinical relationship-building or complex selling.

Model Three: Contractor Marketplace

This is what MDliaison runs, and it's different from both of the above in ways that aren't always obvious.

No setup fees. No minimum contract terms. You engage pre-vetted contractors directly, pay a commission on their hours, and manage them yourself. The rep works exclusively on your account. There's no managed-service layer, which is why the cost is lower — you're not paying for program management infrastructure.

In the comparisons I have seen, contractor marketplace coverage usually lands around 30-45% lower all-in than comparable CSO structures, with faster deployment. I say "usually" on purpose because program shape matters. The biggest practical difference is flexibility: without long minimum terms, you can adjust quickly if the territory underperforms.

The tradeoff is real, though. You're managing the rep. If you don't have that capacity — a regional manager who will actually run onboarding and stay engaged in the first sixty days — this model will underperform regardless of how good the rep is. The VP I mentioned earlier had that capacity. A lot of companies don't, and the CSO model exists for exactly that reason. Related: Medical Sales Outsourcing Pros and Cons.

Which Model Fits

W2 when the territory's proven and you can afford twelve or more weeks to recruit. CSO when you need scale and don't have internal management infrastructure to run contractors. Contractor marketplace when you need fast coverage, you're in a new geography, and you have someone to actually manage the rep.

Where this breaks down: deep spine, complex capital equipment, anything with a long credentialing cycle. The speed advantage of contractors matters less there, and you might cycle through two contractors in a window that would've been better spent on one W2 search. That's a real failure mode worth knowing about.

The VP from February ended up using contractor coverage for both territories. He's three months in. Too early to say if it's working. I'll find out.